Chronic Total Occlusion Crossing With the Wildcat Catheter

Inclusion Criteria

• Patient is willing and able to provide informed consent.
• Patient is willing and able to comply with the study protocol.
• Patient is > 18 years old.
• Patient has peripheral arterial disease requiring revascularization as evidenced by contrast, CT or MR angiography.
• Patient has an occluded femoropopliteal artery that is 99-100% stenosed and is ≥ 1 cm and ≤ 30 cm in length by visual estimate.
• Target femoropopliteal vessel is ≥ 3.0 mm in diameter.
• Patient has Rutherford Classification of 2-5.

Exclusion Criteria

• Patient has a known sensitivity or allergy to contrast materials that cannot be adequately pre-treated.
• Patient has a known sensitivity or allergy to anti-platelet medications.
• Patient is pregnant or lactating.
• Patient has a co-existing disease or medical condition contraindicating percutaneous intervention.
• Target vessel is severely calcified as evidenced by angiography.
• Target lesion is in a bypass graft.
• Target lesion is in a stent (i.e., in-stent restenosis).
• Patient has had a procedure on the target limb within 7 days.
• Patient has had a procedure on the target limb within the past 30 days and is unstable.
• Patient is simultaneously participating in an investigational device or drug study.
• Patient has a planned surgical or interventional procedure within 30 days after the study procedure.